TFX.NYSETeleflex INC

Form 4: Director Gretchen Haggerty Receives Teleflex Equity Grant

Sentiment:

Statement of Changes in Beneficial Ownership


Teleflex Incorporated director Gretchen R. Haggerty was granted 1,090 restricted stock units and 2,397 stock options.

Summary

  • Director Gretchen R. Haggerty acquired 1,090 restricted stock units (RSUs) on May 15, 2026.
  • Director Haggerty was granted 2,397 stock options with an exercise price of $129.71 on May 15, 2026.
  • The total beneficial ownership for the director following these transactions is 7,395 shares of common stock.
  • Both the RSU and stock option awards vest on the one-year anniversary of the grant date, subject to specific conditions regarding board re-election.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine regulatory disclosure regarding director compensation with no material impact on company operations or financial health.

Positives

  • Alignment of director interests with long-term shareholder value through equity-based compensation.
  • Standard retention and incentive structure for board members.

Negatives

  • None identified.

Risks

  • Vesting conditions are contingent upon the director's continued service or specific re-election criteria at the 2027 Annual Meeting.

Future Outlook

The awards are subject to vesting on May 15, 2027, or earlier depending on the director's participation in the 2027 Annual Meeting.

Industry Context

StockSavvy.ai notes that equity grants to non-employee directors are a standard corporate governance practice in the medical device industry to ensure board alignment with shareholder interests.

Comparison to Industry Standards

  • The grant structure is consistent with standard compensation packages for independent directors at mid-to-large cap medical technology firms.
  • Vesting schedules tied to annual meeting cycles are common practice among S&P 500 and mid-cap peers.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Director CompensationGrant of equity awards under the 2023 Stock Incentive Plan.05/15/2026Standard alignment of director incentives.

Stakeholder Impact

  • Minimal impact on shareholders as these are standard equity-based compensation grants.

Next Steps

  • Vesting of RSU and stock option awards on May 15, 2027.

Key Dates

DateDescription
05/15/2026Date of the equity grant and earliest transaction.
05/19/2026Date of filing.
05/15/2036Expiration date of the stock options.

Keywords

Teleflex, TFX, Form 4, Insider Trading, Director Compensation, Equity Grant

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.